Ryuhei Okada
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
-
- Photodynamic Therapy Research Studies
Papers in
-
- Photodynamic Therapy Research Studies 23
- Tracheal and airway disorders 4
-
- Nanoplatforms for cancer theranostics 23
- Co-authors
- Hisataka Kobayashi (39 shared papers)Peter L. Choyke (36 shared papers)Aki Furusawa (34 shared papers)Fuyuki Inagaki (27 shared papers)Takuya Kato (26 shared papers)Hiroaki Wakiyama (25 shared papers)Tadanobu Nagaya (10 shared papers)Yasuhiro Maruoka (9 shared papers)
- Journals
- Cancer Science (6 papers)Cancers (3 papers)Molecular Cancer Therapeutics (3 papers)Cancer Immunology Immunotherapy (3 papers)Bioconjugate Chemistry (2 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
Ryuhei Okada
56 papers receiving 841 citations
Peers
Comparison fields: 5 of 83
- Immunology 339
- Pulmonary and Respiratory Medicine 414
- Biomedical Engineering 408
- Oncology 218
- Biotechnology 63
Countries citing papers authored by Ryuhei Okada
This map shows the geographic impact of Ryuhei Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuhei Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuhei Okada more than expected).
Fields of papers citing papers by Ryuhei Okada
This network shows the impact of papers produced by Ryuhei Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuhei Okada. The network helps show where Ryuhei Okada may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryuhei Okada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 60 | |
| 2 | 2003 | 58 | |
| 3 | 2019 | 45 | |
| 4 | 2014 | 36 | |
| 5 | 2021 | 34 | |
| 6 | 2021 | 32 | |
| 7 | 2020 | 32 | |
| 8 | 2020 | 32 | |
| 9 | 2018 | 31 | |
| 10 | 2022 | 30 | |
| 11 | 2020 | 29 | |
| 12 | 2021 | 26 | |
| 13 | 2021 | 25 | |
| 14 | 2022 | 21 | |
| 15 | 2022 | 21 | |
| 16 | 2021 | 21 | |
| 17 | 2021 | 21 | |
| 18 | 2022 | 21 | |
| 19 | 2021 | 19 | |
| 20 | 2021 | 18 |
About Ryuhei Okada
Ryuhei Okada is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering, Oncology, Immunology and Molecular Biology, having authored 63 papers that have together received 851 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (23 papers), Photodynamic Therapy Research Studies (23 papers), Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (12 papers), Cancer Research and Treatments (7 papers), Head and Neck Cancer Studies (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Tracheal and airway disorders (4 papers). The work is most often cited by research in Immunology (339 citations), Pulmonary and Respiratory Medicine (414 citations), Biomedical Engineering (408 citations), Oncology (218 citations) and Biotechnology (63 citations). Ryuhei Okada has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Hisataka Kobayashi, Peter L. Choyke, Aki Furusawa, Fuyuki Inagaki, Takuya Kato, Hiroaki Wakiyama, Tadanobu Nagaya, Yasuhiro Maruoka, Shuhei Okuyama and Hiroshi Fukushima. Their work appears in journals such as Cancer Science, Cancers, Molecular Cancer Therapeutics, Cancer Immunology Immunotherapy and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.